JG
Julie Grant
OtherQuietGeneral Partner at Canaan Partners
2
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Julie Grant.
Investment Thesis & Strategy
Julie Grant, as a General Partner at Canaan Partners, invests in various stages of companies within the biotech, consumer internet, health & hospital services, health IT, and pharmaceuticals industries. She seeks to partner with innovative companies that are poised for significant growth and market disruption.
Investment Activity
Deals per year over the last 8 years
1
20120
20130
20140
20150
20160
20170
20181
2019Portfolio Companies
Selected investments from their portfolio of 2 companies
S
Synthekine
Biotech · Series B, 2019
P
Protagonist Therapeutics
Biotech · Growth, 2012
Frequently Asked Questions
Julie Grant focuses on Series B, Series A stage investments.
Related Investors
Trevor Oelschig
San Francisco Bay Area, United States · 95 deals
Drew Harman
San Francisco Bay Area, United States · 94 deals
Ben Fletcher
San Francisco Bay Area, United States · 93 deals
Reva Nohria
San Francisco Bay Area, United States · 93 deals
Rajesh Swaminathan
San Francisco Bay Area, United States · 92 deals
Woody Marshall
San Francisco Bay Area, United States · 92 deals